Junling Liu
Hebei Medical University(CN)Xinyang Normal University(CN)Tianjin Normal University(CN)Army Medical University(CN)Jiamusi University(CN)Northeast Agricultural University(CN)Shanghai Jiao Tong University(CN)Shaoyang University(CN)Renji Hospital(CN)Tianjin Medical University General Hospital(CN)Daping Hospital(CN)Second Hospital of Hebei Medical University(CN)First Affiliated Hospital of Jiamusi University(CN)Shenzhen Center for Disease Control and Prevention(CN)Shanghai Cancer Institute(CN)Ministry of Education(TH)Anhui Provincial Center for Disease Control and Prevention(CN)Chengdu University of Traditional Chinese Medicine(CN)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Antiplatelet Therapy and Cardiovascular Diseases, Cell Adhesion Molecules Research, PI3K/AKT/mTOR signaling in cancer, Cancer-related molecular mechanisms research
Most-Cited Works
- → Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK–dependent integrin outside-in retractile signaling pathway(2008)210 cited
- → Hypoxic mitophagy regulates mitochondrial quality and platelet activation and determines severity of I/R heart injury(2016)206 cited
- → Activation of notch‐1 enhances epithelial–mesenchymal transition in gefitinib‐acquired resistant lung cancer cells(2011)185 cited
- → Vitamin D Receptor Activation Protects Against Myocardial Reperfusion Injury Through Inhibition of Apoptosis and Modulation of Autophagy(2014)159 cited
- → Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivo(2006)137 cited
- → Branched-Chain Amino Acid Catabolism Promotes Thrombosis Risk by Enhancing Tropomodulin-3 Propionylation in Platelets(2020)